Health Care System

The Centers for Medicare & Medicaid Services late today issued its proposed rule for the physician fee schedule for calendar year 2018. CMS estimates a 0.31% increase in physician payment rates for 2018 compared to 2017, after applying a 0.5% payment increase required by the Medicare Access and…
Senate Republican leaders today unveiled a revised version of the Better Care Reconciliation Act, legislation to repeal and replace parts of the Affordable Care Act
The Better Care Reconciliation Act would result in 22 million more people uninsured in 2026 and cut $772 billion in federal spending from the Medicaid program from 2017-2026, according to an analysis released today by the Congressional Budget Office.
Senate Republican leaders today unveiled a draft of legislation the Better Care Reconciliation Act to repeal and replace parts of the Affordable Care Act.
The AHA yesterday said the Centers for Medicare & Medicaid Services’ proposed rule for the 2015 Medicare Access and CHIP Reauthorization Act – or MACRA – continues the “incremental, flexible implementation approach called for by hospitals, health systems and the more than 500,000 employed…
With a congressional recess fast approaching, there is significant movement in the Senate on legislation to repeal and replace parts of the Affordable Care Act (ACA) most notably, Senate leadership is expected to release a draft of legislation tomorrow, June 22.
The CMS late yesterday issued a proposed rule updating the requirements of the quality payment program for physicians and other eligible clinicians mandated by the Medicare Access and CHIP Reauthorization Act of 2015.
Senate leaders are expected to unveil a draft of legislation to repeal and replace the Affordable Care Act (ACA) tomorrow, June 22. Below is updated information on what we understand, at this time, is included in the Senate bill.
Reps. Peter Welch (D-VT) and Gregg Harper (R-MS) yesterday introduced the Closing Loopholes for Orphan Drugs Act (H.R. 2889, legislation that would limit the “orphan drug” exclusion for 340B Drug Pricing Program rural and cancer hospitals.